HOME >> BIOLOGY >> NEWS
JCI table of contents, 2 April 2004

Hypertension Tamer

Major diseases of the heart, brain, and kidney all have one thing in common: high-blood pressure as a major risk factor. Hypertension afflicts nearly 50 million people in USA, and over 1 billion worldwide. Although hypertension weighs in heavily on world health, its underlying cause for the vast majority of cases is unknown. One of the known components involved in regulating blood pressure is the beta1subunit of the large Ca2+ activated K+ (BK) channel. The beta1 subunit acts to increase the Ca2+- and voltage-sensitivity of the BK channel, and, intriguingly, it is primarily expressed in smooth muscle tissue in vascular walls. Now, Miguel Valverde and colleagues of the Universitat Pompeu Fabra, have found that a specific mutation in the human beta1-subunit gene, KCNMB1, is associated with lower blood pressure. Carrying out a large epidemiological population-based study, the researchers found an very low frequency (3.2%) of the presence of a single nucleotide substitution (G352A), resulting in a glutamic acid-to-lysine change at amino acid position 65, in KCNMB1 in individuals with extremely high diastolic blood pressure as compared to normotensive individuals (21.6%). That this mutation was so rarely found in individuals with such high diastolic pressure suggested that the beta1subunit with this alteration may provide a protective effect against diastolic hypertension. To see if this mutation affects the action of the BK channel, the authors tested mutant beta1 subunit (beta1E65K) in cell culture and showed that beta1E65K alone or in combination with wild-type beta1 subunit further increased the normal Ca2+- and voltage-sensitivity. These data provide biochemical evidence that this mutation alters the activity of the beta1 subunit in a way that affects BK channel activity and thereby impacts on blood pressure. These data provide compelling reason for investigating the therapeutic potential of agents that target the beta1 subu
'"/>

Contact: Laurie Goodman
lgoodman@the-jci.org
212-342-4159
Journal of Clinical Investigation
2-Apr-2004


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology news :

1. Chemical engineering grad students will take notable national awards
2. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
3. JCI table of contents September 15, 2004
4. JCI table of contents: 1 September, 2004
5. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
6. JCI table of contents, 16 August, 2004
7. JCI table of contents, 2 August, 2004
8. When male fish hum, females swim in, thanks to hormones, adaptable hearing
9. JCI table of contents, 1 July 2004
10. Search and destroy protein turns tables on HIV
11. JCI table of contents, 15 June 2004

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski ... with a near term focus on Type 2 diabetes and associated comorbidities. , ... multiple therapeutic areas and classes. As Chief Commercial Officer, Justin will lead ...
(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming Comparability ... Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, ... is the most effective way to complete one? Will the study comply with ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... publication detailing the use of its revolutionary NEXTGENPCR endpoint thermocycler to test ... 16 minutes. The article, titled "Ultra-fast one-step RT-PCR protocol for the detection ...
Breaking Biology News(10 mins):
(Date:9/3/2020)... ... 03, 2020 , ... The fifth annual AGBT Precision Health ... their latest research and technology in the areas of genomics, medicine, and health. ... therapeutic development, as well as the evolving view of genotype-phenotype interpretation from rare ...
(Date:9/1/2020)... ... September 01, 2020 , ... ... biotechnology, and diagnostics companies, has announced the placement of Julianne Averill , ... responsible for leading all financial operations and implementing key business strategies to accelerate ...
(Date:8/31/2020)... ... August 29, 2020 , ... DuPont ... capability in Wuxi, China. The new plant operation will provide the local animal ... technology. , “This facility will improve the flexibility of our offerings to ...
(Date:8/15/2020)... ... August 13, 2020 , ... True Terpenes , the leading ... Scientific Advisory Board (SAB) to research the medical potential of terpenes and the potential ... combined with terpenes. The board is focused on expanding the recently launched line of ...
Breaking Biology Technology:
Cached News: